RPM Plus Map Prescription Pills Image Visit the MSH Web Site  
Pattern
Rational Pharmaceutical Management Plus (RPM Plus)  
  Graduated Bar    
 
Search RPM Plus Site:


Malaria

Malaria causes an estimated 300 to 500 million cases of acute illness worldwide each year, resulting in more than one million deaths. Those most vulnerable include children under five years, pregnant women, and people with little or no immunity to malaria, such as travelers or people living with HIV/AIDS.

The impact is most striking in Africa, where more than 80 percent of malaria cases and deaths occur, but malaria is also a significant public health problem in areas of Asia and Latin America.

Patient receiving medicationA major current challenge in malaria control is combating drug resistance. The most deadly of the malaria parasites, Plasmodium falciparum, has become resistant to chloroquine (CQ), the mainstay of malaria treatment for more than 50 years.

The most common CQ replacement has been sulfadoxine-pyrimethamine (SP), but this drug is also losing effectiveness in many areas.

Artemisinin-based combination therapies (ACTs) are now recommended where resistance has been documented. However, significant efforts are required to expand their availability and appropriate use worldwide.

Read how RPM Plus is responding to the Malaria crisis

HIGHLIGHTS

ACT Guide

» Download Changing Malaria Treatment Policy to Artemisinin-Based Combinations: An Implementation Guide[PDF-352KB]

Malaria Brochure

» View the Malaria Brochure[PDF-1.1MB]


» Read the Report on the PMM Cambodia National Training Course

» Read about the RBM Procurement and Supply Management Working Group Meeting, July 9-10, 2007